-
1
-
-
0347423198
-
Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
-
1:CAS:528:DC%2BD3sXpsVGisL4%3D 14656957 10.1161/01.HYP.0000107251.49515. c2
-
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 42(6):1206-1252
-
(2003)
Hypertension
, vol.42
, Issue.6
, pp. 1206-1252
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo, Jr.J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright, Jr.J.T.10
Roccella, E.J.11
-
2
-
-
84876739213
-
Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations
-
1:CAS:528:DC%2BC3sXkslSms7k%3D 23316965
-
Castro MM, Tanus-Santos JE (2013) Inhibition of matrix metalloproteinases (MMPs) as a potential strategy to ameliorate hypertension-induced cardiovascular alterations. Curr Drug Targets 14(3):335-343
-
(2013)
Curr Drug Targets
, vol.14
, Issue.3
, pp. 335-343
-
-
Castro, M.M.1
Tanus-Santos, J.E.2
-
3
-
-
0242330196
-
Prognostic significance of small-artery structure in hypertension
-
14557363 10.1161/01.CIR.0000095031.51492.C5
-
Rizzoni D, Porteri E, Boari GE, De Ciuceis C, Sleiman I, Muiesan ML, Castellano M, Miclini M, Agabiti-Rosei E (2003) Prognostic significance of small-artery structure in hypertension. Circulation 108(18):2230-2235
-
(2003)
Circulation
, vol.108
, Issue.18
, pp. 2230-2235
-
-
Rizzoni, D.1
Porteri, E.2
Boari, G.E.3
De Ciuceis, C.4
Sleiman, I.5
Muiesan, M.L.6
Castellano, M.7
Miclini, M.8
Agabiti-Rosei, E.9
-
4
-
-
80054110244
-
Matrix metalloproteinases: Targets for doxycycline to prevent the vascular alterations of hypertension
-
1:CAS:528:DC%2BC3MXhtlChs73I 21514386 10.1016/j.phrs.2011.04.002
-
Castro MM, Tanus-Santos JE, Gerlach RF (2011) Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension. Pharmacol Res 64(6):567-572
-
(2011)
Pharmacol Res
, vol.64
, Issue.6
, pp. 567-572
-
-
Castro, M.M.1
Tanus-Santos, J.E.2
Gerlach, R.F.3
-
5
-
-
0037155057
-
Matrix metalloproteinases in vascular remodeling and atherogenesis: The good, the bad, and the ugly
-
1:CAS:528:DC%2BD38Xhs1Wrsb4%3D 11861412
-
Galis ZS, Khatri JJ (2002) Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res 90(3):251-262
-
(2002)
Circ Res
, vol.90
, Issue.3
, pp. 251-262
-
-
Galis, Z.S.1
Khatri, J.J.2
-
6
-
-
77953758874
-
Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats
-
1:CAS:528:DC%2BC3cXpsVOrsrk%3D 20382857 10.1152/ajpheart.00620.2009
-
Rodrigues SF, Tran ED, Fortes ZB, Schmid-Schonbein GW (2010) Matrix metalloproteinases cleave the beta2-adrenergic receptor in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 299(1):H25-H35
-
(2010)
Am J Physiol Heart Circ Physiol
, vol.299
, Issue.1
-
-
Rodrigues, S.F.1
Tran, E.D.2
Fortes, Z.B.3
Schmid-Schonbein, G.W.4
-
7
-
-
84872124323
-
Recombinant human matrix metalloproteinase-2 impairs cardiovascular beta-adrenergic responses
-
1:CAS:528:DC%2BC3sXjtFCrtLc%3D 22913757 10.1111/bcpt.12001
-
Ferraz KC, Sousa-Santos O, Neto-Neves EM, Rizzi E, Muniz JJ, Gerlach RF, Tanus-Santos JE (2013) Recombinant human matrix metalloproteinase-2 impairs cardiovascular beta-adrenergic responses. Basic Clin Pharmacol Toxicol 112(2):103-109
-
(2013)
Basic Clin Pharmacol Toxicol
, vol.112
, Issue.2
, pp. 103-109
-
-
Ferraz, K.C.1
Sousa-Santos, O.2
Neto-Neves, E.M.3
Rizzi, E.4
Muniz, J.J.5
Gerlach, R.F.6
Tanus-Santos, J.E.7
-
8
-
-
43949099942
-
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
-
1:CAS:528:DC%2BD1cXmtlSqsb4%3D 18054360 10.1016/j.atherosclerosis.2007. 10.011
-
Castro MM, Rizzi E, Figueiredo-Lopes L, Fernandes K, Bendhack LM, Pitol DL, Gerlach RF, Tanus-Santos JE (2008) Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 198(2):320-331
-
(2008)
Atherosclerosis
, vol.198
, Issue.2
, pp. 320-331
-
-
Castro, M.M.1
Rizzi, E.2
Figueiredo-Lopes, L.3
Fernandes, K.4
Bendhack, L.M.5
Pitol, D.L.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
9
-
-
79954524108
-
Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension
-
1:CAS:528:DC%2BC3MXls1OrsL0%3D 21176109 10.1111/j.1742-7843.2010.00656.x
-
Guimaraes DA, Rizzi E, Ceron CS, Oliveira AM, Oliveira DM, Castro MM, Tirapelli CR, Gerlach RF, Tanus-Santos JE (2011) Doxycycline dose-dependently inhibits MMP-2-mediated vascular changes in 2K1C hypertension. Basic Clin Pharmacol Toxicol 108(5):318-325
-
(2011)
Basic Clin Pharmacol Toxicol
, vol.108
, Issue.5
, pp. 318-325
-
-
Guimaraes, D.A.1
Rizzi, E.2
Ceron, C.S.3
Oliveira, A.M.4
Oliveira, D.M.5
Castro, M.M.6
Tirapelli, C.R.7
Gerlach, R.F.8
Tanus-Santos, J.E.9
-
10
-
-
14644401767
-
Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition
-
1:CAS:528:DC%2BD2MXhtlOisLs%3D 15655118 10.1161/01.HYP.0000154680.44184. 01
-
Bouvet C, Gilbert LA, Girardot D, deBlois D, Moreau P (2005) Different involvement of extracellular matrix components in small and large arteries during chronic NO synthase inhibition. Hypertension 45(3):432-437
-
(2005)
Hypertension
, vol.45
, Issue.3
, pp. 432-437
-
-
Bouvet, C.1
Gilbert, L.A.2
Girardot, D.3
Deblois, D.4
Moreau, P.5
-
11
-
-
34250796742
-
Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats
-
1:CAS:528:DC%2BD2sXlslShs7s%3D 17237246 10.1152/ajpheart.00900.2006
-
Watts SW, Rondelli C, Thakali K, Li X, Uhal B, Pervaiz MH, Watson RE, Fink GD (2007) Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 292(5):H2438-H2448
-
(2007)
Am J Physiol Heart Circ Physiol
, vol.292
, Issue.5
-
-
Watts, S.W.1
Rondelli, C.2
Thakali, K.3
Li, X.4
Uhal, B.5
Pervaiz, M.H.6
Watson, R.E.7
Fink, G.D.8
-
12
-
-
34250827318
-
Role of matrix metalloproteinases in early hypertensive vascular remodeling
-
1:CAS:528:DC%2BD2sXmtlKqs7o%3D 17515450 10.1161/HYPERTENSIONAHA.107. 089631
-
Flamant M, Placier S, Dubroca C, Esposito B, Lopes I, Chatziantoniou C, Tedgui A, Dussaule JC, Lehoux S (2007) Role of matrix metalloproteinases in early hypertensive vascular remodeling. Hypertension 50(1):212-218
-
(2007)
Hypertension
, vol.50
, Issue.1
, pp. 212-218
-
-
Flamant, M.1
Placier, S.2
Dubroca, C.3
Esposito, B.4
Lopes, I.5
Chatziantoniou, C.6
Tedgui, A.7
Dussaule, J.C.8
Lehoux, S.9
-
13
-
-
0347951238
-
Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway
-
1:CAS:528:DC%2BD2cXhtFWi 14656925 10.1161/01.RES.0000109413.57726.91
-
Hao L, Du M, Lopez-Campistrous A, Fernandez-Patron C (2004) Agonist-induced activation of matrix metalloproteinase-7 promotes vasoconstriction through the epidermal growth factor-receptor pathway. Circ Res 94(1):68-76
-
(2004)
Circ Res
, vol.94
, Issue.1
, pp. 68-76
-
-
Hao, L.1
Du, M.2
Lopez-Campistrous, A.3
Fernandez-Patron, C.4
-
14
-
-
4444286972
-
Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: A substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
-
1:CAS:528:DC%2BD2cXnsFSmtLs%3D 15363817
-
Tayebjee MH, Nadar S, Blann AD, Gareth Beevers D, MacFadyen RJ, Lip GY (2004) Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in hypertension and their relationship to cardiovascular risk and treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Am J Hypertens 17(9):764-769
-
(2004)
Am J Hypertens
, vol.17
, Issue.9
, pp. 764-769
-
-
Tayebjee, M.H.1
Nadar, S.2
Blann, A.D.3
Gareth Beevers, D.4
Macfadyen, R.J.5
Lip, G.Y.6
-
15
-
-
84876412031
-
Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension
-
1:CAS:528:DC%2BC38XhslyjsbbJ 23085896 10.1007/s10557-012-6420-2
-
Fontana V, Silva PS, Izidoro-Toledo TC, Biagi C, Oliveira EB, Gerlach RF, Tanus-Santos JE (2012) Comprehensive evaluation of the effects of enalapril on matrix metalloproteinases levels in hypertension. Cardiovasc Drugs Ther 26(6):511-519
-
(2012)
Cardiovasc Drugs Ther
, vol.26
, Issue.6
, pp. 511-519
-
-
Fontana, V.1
Silva, P.S.2
Izidoro-Toledo, T.C.3
Biagi, C.4
Oliveira, E.B.5
Gerlach, R.F.6
Tanus-Santos, J.E.7
-
16
-
-
79960227472
-
Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: A relevant pharmacological target
-
1:CAS:528:DC%2BC3MXpvVSjsr4%3D 21401887 10.1111/j.1742-7843.2011.00698.x
-
Fontana V, Silva PS, Belo VA, Antonio RC, Ceron CS, Biagi C, Gerlach RF, Tanus-Santos JE (2011) Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target. Basic Clin Pharmacol Toxicol 109(2):130-137
-
(2011)
Basic Clin Pharmacol Toxicol
, vol.109
, Issue.2
, pp. 130-137
-
-
Fontana, V.1
Silva, P.S.2
Belo, V.A.3
Antonio, R.C.4
Ceron, C.S.5
Biagi, C.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
17
-
-
84857656374
-
Circulating matrix metalloproteinases and their inhibitors in hypertension
-
1:CAS:528:DC%2BC38Xjt1enu7w%3D 22245508 10.1016/j.cca.2011.12.021
-
Fontana V, Silva PS, Gerlach RF, Tanus-Santos JE (2012) Circulating matrix metalloproteinases and their inhibitors in hypertension. Clin Chim Acta 413(7-8):656-662
-
(2012)
Clin Chim Acta
, vol.413
, Issue.7-8
, pp. 656-662
-
-
Fontana, V.1
Silva, P.S.2
Gerlach, R.F.3
Tanus-Santos, J.E.4
-
18
-
-
1842738493
-
Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug
-
1:CAS:528:DC%2BD2cXjs1OrtLo%3D 15088884 10.1902/jop.2004.75.3.453
-
Lee HM, Ciancio SG, Tuter G, Ryan ME, Komaroff E, Golub LM (2004) Subantimicrobial dose doxycycline efficacy as a matrix metalloproteinase inhibitor in chronic periodontitis patients is enhanced when combined with a non-steroidal anti-inflammatory drug. J Periodontol 75(3):453-463
-
(2004)
J Periodontol
, vol.75
, Issue.3
, pp. 453-463
-
-
Lee, H.M.1
Ciancio, S.G.2
Tuter, G.3
Ryan, M.E.4
Komaroff, E.5
Golub, L.M.6
-
19
-
-
0025025442
-
The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family
-
2164689 10.1073/pnas.87.14.5578
-
Van Wart HE, Birkedal-Hansen H (1990) The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc Natl Acad Sci USA 87(14):5578-5582
-
(1990)
Proc Natl Acad Sci USA
, vol.87
, Issue.14
, pp. 5578-5582
-
-
Van Wart, H.E.1
Birkedal-Hansen, H.2
-
20
-
-
0027371852
-
Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase
-
1:CAS:528:DyaK2cXktVSrsLw%3D 8256662 10.1002/jbmr.5650081013
-
Ramamurthy NS, Vernillo AT, Greenwald RA, Lee HM, Sorsa T, Golub LM, Rifkin BR (1993) Reactive oxygen species activate and tetracyclines inhibit rat osteoblast collagenase. J Bone Miner Res 8(10):1247-1253
-
(1993)
J Bone Miner Res
, vol.8
, Issue.10
, pp. 1247-1253
-
-
Ramamurthy, N.S.1
Vernillo, A.T.2
Greenwald, R.A.3
Lee, H.M.4
Sorsa, T.5
Golub, L.M.6
Rifkin, B.R.7
-
21
-
-
84859099989
-
Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability
-
1:CAS:528:DC%2BC38XisFOqtL8%3D 22327038 10.1016/j.niox.2012.01.009
-
Castro MM, Rizzi E, Ceron CS, Guimaraes DA, Rodrigues GJ, Bendhack LM, Gerlach RF, Tanus-Santos JE (2012) Doxycycline ameliorates 2K-1C hypertension-induced vascular dysfunction in rats by attenuating oxidative stress and improving nitric oxide bioavailability. Nitric Oxide 26(3):162-168
-
(2012)
Nitric Oxide
, vol.26
, Issue.3
, pp. 162-168
-
-
Castro, M.M.1
Rizzi, E.2
Ceron, C.S.3
Guimaraes, D.A.4
Rodrigues, G.J.5
Bendhack, L.M.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
22
-
-
25644445991
-
Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism
-
16193201 10.1177/000331970505600513
-
Palei AC, Zaneti RA, Fortuna GM, Gerlach RF, Tanus-Santos JE (2005) Hemodynamic benefits of matrix metalloproteinase-9 inhibition by doxycycline during experimental acute pulmonary embolism. Angiology 56(5):611-617
-
(2005)
Angiology
, vol.56
, Issue.5
, pp. 611-617
-
-
Palei, A.C.1
Zaneti, R.A.2
Fortuna, G.M.3
Gerlach, R.F.4
Tanus-Santos, J.E.5
-
23
-
-
77950930269
-
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension
-
1:CAS:528:DC%2BC3cXpslyqtL8%3D 20331602 10.1111/j.1476-5381.2010.00678.x
-
Ceron CS, Castro MM, Rizzi E, Montenegro MF, Fontana V, Salgado MC, Gerlach RF, Tanus-Santos JE (2010) Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Br J Pharmacol 160(1):77-87
-
(2010)
Br J Pharmacol
, vol.160
, Issue.1
, pp. 77-87
-
-
Ceron, C.S.1
Castro, M.M.2
Rizzi, E.3
Montenegro, M.F.4
Fontana, V.5
Salgado, M.C.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
24
-
-
48749128063
-
Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats
-
1:CAS:528:DC%2BD1cXps12ltrs%3D 18634778 10.1016/j.ejphar.2008.06.096
-
Martinez ML, Castro MM, Rizzi E, Fernandes K, Demacq C, Bendhack LM, Gerlach RF, Tanus-Santos JE (2008) Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats. Eur J Pharmacol 591(1-3):224-230
-
(2008)
Eur J Pharmacol
, vol.591
, Issue.1-3
, pp. 224-230
-
-
Martinez, M.L.1
Castro, M.M.2
Rizzi, E.3
Fernandes, K.4
Demacq, C.5
Bendhack, L.M.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
25
-
-
63349099519
-
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
-
1:CAS:528:DC%2BD1MXkt1ShsLo%3D 19248829 10.1016/j.freeradbiomed.2009.02. 011
-
Castro MM, Rizzi E, Rodrigues GJ, Ceron CS, Bendhack LM, Gerlach RF, Tanus-Santos JE (2009) Antioxidant treatment reduces matrix metalloproteinase-2- induced vascular changes in renovascular hypertension. Free Radic Biol Med 46(9):1298-1307
-
(2009)
Free Radic Biol Med
, vol.46
, Issue.9
, pp. 1298-1307
-
-
Castro, M.M.1
Rizzi, E.2
Rodrigues, G.J.3
Ceron, C.S.4
Bendhack, L.M.5
Gerlach, R.F.6
Tanus-Santos, J.E.7
-
26
-
-
84860271653
-
Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension
-
1:CAS:528:DC%2BC38Xjt1GqurY%3D 22342460 10.1016/j.matbio.2012.01.009
-
Ceron CS, Rizzi E, Guimaraes DA, Martins-Oliveira A, Cau SB, Ramos J, Gerlach RF, Tanus-Santos JE (2012) Time course involvement of matrix metalloproteinases in the vascular alterations of renovascular hypertension. Matrix Biol 31(4):261-270
-
(2012)
Matrix Biol
, vol.31
, Issue.4
, pp. 261-270
-
-
Ceron, C.S.1
Rizzi, E.2
Guimaraes, D.A.3
Martins-Oliveira, A.4
Cau, S.B.5
Ramos, J.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
27
-
-
80051956734
-
Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension
-
1:CAS:528:DC%2BC3MXhtFWqsLbF 21434884 10.1111/j.1476-5381.2011.01360.x
-
Cau SB, Guimaraes DA, Rizzi E, Ceron CS, Souza LL, Tirapelli CR, Gerlach RF, Tanus-Santos JE (2011) Pyrrolidine dithiocarbamate down-regulates vascular matrix metalloproteinases and ameliorates vascular dysfunction and remodelling in renovascular hypertension. Br J Pharmacol 164(2):372-381
-
(2011)
Br J Pharmacol
, vol.164
, Issue.2
, pp. 372-381
-
-
Cau, S.B.1
Guimaraes, D.A.2
Rizzi, E.3
Ceron, C.S.4
Souza, L.L.5
Tirapelli, C.R.6
Gerlach, R.F.7
Tanus-Santos, J.E.8
-
28
-
-
0022968401
-
Is the spontaneously hypertensive rat a model for human hypertension?
-
1:STN:280:DyaL2s%2FmtVWkug%3D%3D 2946825
-
Frohlich ED (1986) Is the spontaneously hypertensive rat a model for human hypertension? J Hypertens Suppl 4(3):S15-S19
-
(1986)
J Hypertens Suppl
, vol.4
, Issue.3
-
-
Frohlich, E.D.1
-
29
-
-
0031037546
-
Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats
-
1:CAS:528:DyaK2sXhsFOnsbg%3D 9039125 10.1161/01.HYP.29.1.340
-
deBlois D, Tea BS, Than VD, Tremblay J, Hamet P (1997) Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 29(1 Pt 2):340-349
-
(1997)
Hypertension
, vol.29
, Issue.1 PART 2
, pp. 340-349
-
-
Deblois, D.1
Tea, B.S.2
Than, V.D.3
Tremblay, J.4
Hamet, P.5
-
30
-
-
79959901572
-
Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats
-
1:CAS:528:DC%2BC3MXptlSgtL4%3D 21551278 10.1152/ajpheart.01206.2010
-
Pires PW, Rogers CT, McClain JL, Garver HS, Fink GD, Dorrance AM (2011) Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 301(1):H87-H97
-
(2011)
Am J Physiol Heart Circ Physiol
, vol.301
, Issue.1
-
-
Pires, P.W.1
Rogers, C.T.2
McClain, J.L.3
Garver, H.S.4
Fink, G.D.5
Dorrance, A.M.6
-
31
-
-
77955772042
-
Doxycycline suppresses doxorubicin-induced oxidative stress and cellular apoptosis in mouse hearts
-
1:CAS:528:DC%2BC3cXhtVejs7nK 20655905 10.1016/j.ejphar.2010.07.010
-
Lai HC, Yeh YC, Ting CT, Lee WL, Lee HW, Wang LC, Wang KY, Lai HC, Wu A, Liu TJ (2010) Doxycycline suppresses doxorubicin-induced oxidative stress and cellular apoptosis in mouse hearts. Eur J Pharmacol 644(1-3):176-187
-
(2010)
Eur J Pharmacol
, vol.644
, Issue.1-3
, pp. 176-187
-
-
Lai, H.C.1
Yeh, Y.C.2
Ting, C.T.3
Lee, W.L.4
Lee, H.W.5
Wang, L.C.6
Wang, K.Y.7
Lai, H.C.8
Wu, A.9
Liu, T.J.10
-
32
-
-
77956562826
-
Tetracyclines: A pleitropic family of compounds with promising therapeutic properties. Review of the literature
-
1:CAS:528:DC%2BC3cXht1Wgu7rI 20592239 10.1152/ajpcell.00047.2010
-
Griffin MO, Fricovsky E, Ceballos G, Villarreal F (2010) Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299(3):C539-C548
-
(2010)
Am J Physiol Cell Physiol
, vol.299
, Issue.3
-
-
Griffin, M.O.1
Fricovsky, E.2
Ceballos, G.3
Villarreal, F.4
-
33
-
-
66749149848
-
Role of NF-kappaB in flow-induced vascular remodeling
-
1:CAS:528:DC%2BD1MXmsVCmsbY%3D 19320561 10.1089/ars.2008.2393
-
Castier Y, Ramkhelawon B, Riou S, Tedgui A, Lehoux S (2009) Role of NF-kappaB in flow-induced vascular remodeling. Antioxid Redox Signal 11(7):1641-1649
-
(2009)
Antioxid Redox Signal
, vol.11
, Issue.7
, pp. 1641-1649
-
-
Castier, Y.1
Ramkhelawon, B.2
Riou, S.3
Tedgui, A.4
Lehoux, S.5
|